FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alain Fournier

Research Profile

Chemicals & Drugs

Living Beings

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
David Chatenet; J Dupuis; M Létourneau; N D Doan; Q T Nguyen; Alain Fournier
Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.
Magali Basille-Dugay; Alain Fournier; Bruno Gonzalez; Hubert Vaudry; David Vaudry
Activation of PAC1 Receptors in Rat Cerebellar Granule Cells Stimulates Both Calcium Mobilization from Intracellular Stores and Calcium Influx through N-Type Calcium Channels.
Ngoc-Duc Doan; Nicolas Doucet; Benjamin Folch; Alain Fournier; Myriam Létourneau; David Vaudry; Hubert Vaudry; David Chatenet
Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alain Fournier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David Chatenet; J Dupuis; M Létourneau; N D Doan; Q T Nguyen; Alain Fournier
Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.
British journal of pharmacology 2013;168(4):807-21.
2013: Magali Basille-Dugay; Alain Fournier; Bruno Gonzalez; Hubert Vaudry; David Vaudry
Activation of PAC1 Receptors in Rat Cerebellar Granule Cells Stimulates Both Calcium Mobilization from Intracellular Stores and Calcium Influx through N-Type Calcium Channels.
Frontiers in endocrinology 2013;4():56.
2012: Ngoc-Duc Doan; Nicolas Doucet; Benjamin Folch; Alain Fournier; Myriam Létourneau; David Vaudry; Hubert Vaudry; David Chatenet
Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide.
Journal of controlled release : official journal of the Controlled Release Society 2012;163(2):256-65.
2012: Thi Tuyet Nhung Nguyen; Nam Hai Truong; David Vaudry; Myriam Létourneau; David Chatenet; Nicolas Doucet; Benjamin Folch; Alain Fournier
Cardiotoxin-I: an unexpectedly potent insulinotropic agent.
Chembiochem : a European journal of chemical biology 2012;13(12):1805-12.
2012: N D Doan; T T M Nguyen; Alain Fournier; M Létourneau; K Turcotte; David Chatenet
Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart.
British journal of pharmacology 2012;166(1):243-57.
2012: Ngoc-Duc Doan; Myriam Létourneau; David Vaudry; Hubert Vaudry; David Chatenet; Alain Fournier
Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide.
Biochimica et biophysica acta 2012;1823(4):940-9.
2012: Thi-Tuyet Mai Nguyen; Myriam Létourneau; David Chatenet; Alain Fournier
Presence of urotensin-II receptors at the cell nucleus: specific tissue distribution and hypoxia-induced modulation.
The international journal of biochemistry & cell biology 2012;44(4):639-47.
2012: David Chatenet; Jocelyn Dupuis; Myriam Létourneau; Quang Trinh Nguyen; Alain Fournier
Urocontrin, a novel UT receptor ligand with a unique pharmacological profile.
Biochemical pharmacology 2012;83(5):608-15.
2012: David Chatenet; Myriam Létourneau; Thi-Tuyet M Nguyen; Alain Fournier
Update on the urotensinergic system: new trends in receptor localization, activation, and drug design.
Frontiers in endocrinology 2012;3():174.
2011: Driss El Kebir; Alain Fournier; Lawrence Potempa; Yi Wu; Ying Zhang; János G Filep
C-reactive protein-derived peptide 201-206 inhibits neutrophil adhesion to endothelial cells and platelets through CD32.
Journal of leukocyte biology 2011;90(6):1167-75.
2011: Yan Fu; Myriam Létourneau; David Chatenet; Jocelyn Dupuis; Alain Fournier
Characterization of iodinated adrenomedullin derivatives suitable for lung nuclear medicine.
Nuclear medicine and biology 2011;38(6):867-74.
2011: Béatrice Botia; Valérie Jolivel; Delphine Burel; Vadim Le Joncour; Vincent Roy; Mickael Naassila; Magalie Bénard; Alain Fournier; Hubert Vaudry; David Vaudry
Neuroprotective effects of PACAP against ethanol-induced toxicity in the developing rat cerebellum.
Neurotoxicity research 2011;19(3):423-34.
2011: Ngoc-Duc Doan; Steve Bourgault; Agnieszka Dejda; Myriam Létourneau; Michel detheux; David Vaudry; Hubert Vaudry; David Chatenet; Alain Fournier
Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects.
Biochemical pharmacology 2011;81(4):552-61.
2011: S Bourgault; David Chatenet; O Wurtz; N D Doan; Jérôme Leprince; Hubert Vaudry; Alain Fournier; David Vaudry
Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug.
Current pharmaceutical design 2011;17(10):1002-24.
2011: Tommy Seaborn; Olfa Masmoudi-Kouli; Alain Fournier; Hubert Vaudry; David Vaudry
Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis.
Current pharmaceutical design 2011;17(3):204-14.
2010: Agnieszka Dejda; Philippe Chan; Tommy Seaborn; Laurent Coquet; THIERRY JOUENNE; Alain Fournier; Hubert Vaudry; David Vaudry
Involvement of stathmin 1 in the neurotrophic effects of PACAP in PC12 cells.
Journal of neurochemistry 2010;114(5):1498-510.
2010: Hubert Vaudry; Jean-Claude do-Rego; Jean-Claude Le Mevel; David Chatenet; Hervé Tostivint; Alain Fournier; Marie-Christine Tonon; Georges Pelletier; J Michael Conlon; Jérôme Leprince
Urotensin II, from fish to human.
Annals of the New York Academy of Sciences 2010;1200():53-66.
2010: Aurélie Allais; Delphine Burel; Vincent Roy; Sébastien Arthaud; Ludovic Galas; Emma R Isaac; Arnaud Desfeux; Bénédicte Parent; Alain Fournier; Pierre Chapillon; Nancy M Sherwood; Hubert Vaudry; Bruno J Gonzalez
Balanced effect of PACAP and FasL on granule cell death during cerebellar development: a morphological, functional and behavioural characterization.
Journal of neurochemistry 2010;113(2):329-40.
2009: David Vaudry; Anthony Falluel-Morel; Steve Bourgault; Magali Basille; Delphine Burel; Olivier Wurtz; Alain Fournier; Billy K C Chow; Hitoshi Hashimoto; Ludovic Galas; Hubert Vaudry
Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.
Pharmacological reviews 2009;61(3):283-357.
2009: Yan Fu; Myriam Létourneau; Quang T Nguyen; David Chatenet; Jocelyn Dupuis; Alain Fournier
Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging.
European journal of pharmacology 2009;617(1-3):118-23.
2009: Thomas Lefebvre; Bruno J Gonzalez; David Vaudry; Laurence Desrues; Anthony Falluel-Morel; Nicolas Aubert; Alain Fournier; Marie-Christine Tonon; Hubert Vaudry; Hélène Castel
Paradoxical effect of ethanol on potassium channel currents and cell survival in cerebellar granule neurons.
Journal of neurochemistry 2009;110(3):976-89.
2009: Steve Bourgault; David Vaudry; Isabelle Ségalas-Milazzo; Laure Guilhaudis; Alain Couvineau; Marc Laburthe; Hubert Vaudry; Alain Fournier
Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.
Journal of medicinal chemistry 2009;52(10):3308-16.
2009: Valérie Jolivel; Magali Basille; Nicolas Aubert; Stéphane De Jouffrey; Philippe Ancian; J-F Le Bigot; P Noack; Marc Massonneau; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez; David Vaudry
Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
Neuroscience 2009;160(2):434-51.
2009: S Bourgault; D Vaudry; A Dejda; N D Doan; Hubert Vaudry; Alain Fournier
Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide.
Current medicinal chemistry 2009;16(33):4462-80.
2008: Agnieszka Dejda; Valérie Jolivel; Steve Bourgault; Tommy Seaborn; Alain Fournier; Hubert Vaudry; David Vaudry
Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases.
Journal of molecular neuroscience : MN 2008;36(1-3):26-37.
2008: Béatrice Botia; Damien Seyer; Aurélia Ravni; Magalie Bénard; Anthony Falluel-Morel; Pascal Cosette; THIERRY JOUENNE; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez; David Vaudry
Peroxiredoxin 2 is involved in the neuroprotective effects of PACAP in cultured cerebellar granule neurons.
Journal of molecular neuroscience : MN 2008;36(1-3):61-72.
2008: Steve Bourgault; David Vaudry; Laure Guilhaudis; Emilie Raoult; Alain Couvineau; Marc Laburthe; Isabelle Ségalas-Milazzo; Hubert Vaudry; Alain Fournier
Biological and structural analysis of truncated analogs of PACAP27.
Journal of molecular neuroscience : MN 2008;36(1-3):260-9.
2008: Nicolas Aubert; David Vaudry; Anthony Falluel-Morel; Arnaud Desfeux; Cecile Fisch; Philippe Ancian; Stéphane De Jouffrey; Jean-François Le Bigot; Alain Couvineau; Marc Laburthe; Alain Fournier; Vincent Laudenbach; Hubert Vaudry; Bruno J Gonzalez
PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: involvement of the mitochondrial apoptotic pathway.
Neurobiology of disease 2008;32(1):66-80.
2008: S S Zhokhov; A Desfeux; Nicolas Aubert; Anthony Falluel-Morel; Alain Fournier; V Laudenbach; Hubert Vaudry; Bruno J Gonzalez
Bax siRNA promotes survival of cultured and allografted granule cell precursors through blockade of caspase-3 cleavage.
Cell death and differentiation 2008;15(6):1042-53.
2008: Luca Grumolato; Hafida Ghzili; Maite Montero-Hadjadje; Stéphane Gasman; Jean Lesage; Yannick Tanguy; Ludovic Galas; Djida Ait-Ali; Jérôme Leprince; Nathalie C Guérineau; Abdel G Elkahloun; Alain Fournier; Didier Vieau; Hubert Vaudry; Youssef Anouar
Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(6):1756-68.
2008: Stéphane Boivin; Isabelle Ségalas-Milazzo; Laure Guilhaudis; Hassan Oulyadi; Alain Fournier; Daniel Davoust
Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II.
Peptides 2008;29(5):700-10.
2008: Jérôme Leprince; David Chatenet; Christophe Dubessy; Alain Fournier; Bruno Pfeiffer; Elizabeth Scalbert; Pierre Renard; Pierre Pacaud; Hassan Oulyadi; Isabelle Ségalas-Milazzo; Laure Guilhaudis; Daniel Davoust; Marie-Christine Tonon; Hubert Vaudry
Structure-activity relationships of urotensin II and URP.
Peptides 2008;29(5):658-73.
2008: Marie Parat; Normand McNicoll; Brian C Wilkes; Alain Fournier; André De Léan
Role of extracellular domain dimerization in agonist-induced activation of natriuretic peptide receptor A.
Molecular pharmacology 2008;73(2):431-40.
2007: Eurode Legros; Carlos R Tirapelli; Emilie Carrier; Isabelle Brochu; Alain Fournier; Pedro D'Orléans-Juste
Characterization of the non-adrenergic/non-cholinergic response to perivascular nerve stimulation in the double-perfused mesenteric bed of the mouse.
British journal of pharmacology 2007;152(7):1049-59.
2007: Nicolas Aubert; Magali Basille; Anthony Falluel-Morel; David Vaudry; Christine Bucharles; Valérie Jolivel; Cecile Fisch; Stéphane De Jouffrey; Jean-Francois Le Bigot; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
The Journal of comparative neurology 2007;504(4):427-39.
2007: Olfa Masmoudi-Kouki; Pierrick Gandolfo; Hélène Castel; Jérôme Leprince; Alain Fournier; Agnieszka Dejda; Hubert Vaudry; Marie-Christine Tonon
Role of PACAP and VIP in astroglial functions.
Peptides 2007;28(9):1753-60.
2007: Béatrice Botia; Magali Basille; Aurélie Allais; Emilie Raoult; Anthony Falluel-Morel; Ludovic Galas; Valérie Jolivel; Olivier Wurtz; Hitoshi Komuro; Alain Fournier; Hubert Vaudry; Delphine Burel; Bruno J Gonzalez; David Vaudry
Neurotrophic effects of PACAP in the cerebellar cortex.
Peptides 2007;28(9):1746-52.
2007: Anthony Falluel-Morel; M Chafai; David Vaudry; Magali Basille; Michèle Cazillis; Nicolas Aubert; Estelle Louiset; Stéphane De Jouffrey; J F Le Bigot; Alain Fournier; Pierre Gressens; William Rostène; Hubert Vaudry; Bruno J Gonzalez
The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells.
Journal of neuroendocrinology 2007;19(5):321-7.
2007: S Bourgault; M Létourneau; Alain Fournier
Development of photolabile caged analogs of endothelin-1.
Peptides 2007;28(5):1074-82.
2007: Yvan Dumont; Emmanuel Moyse; Alain Fournier; Rémi Quirion
Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema.
Journal of molecular neuroscience : MN 2007;33(3):294-304.
2006: Lourdes Mounien; Patrice Bizet; Isabelle Boutelet; Guillaume Gourcerol; Alain Fournier; Hubert Vaudry; Sylvie Jégou
Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
Neuroscience 2006;143(1):155-63.
2006: Magali Basille; Anthony Falluel-Morel; David Vaudry; Nicolas Aubert; Alain Fournier; Pierre Fréger; Nicole Gallo-Payet; Hubert Vaudry; Bruno Gonzalez
Ontogeny of PACAP receptors in the human cerebellum: perspectives of therapeutic applications.
Regulatory peptides 2006;137(1-2):27-33.
2006: Johann Guillemot; Djida Aït-Ali; Valérie Turquier; Maite Montero-Hadjadje; Alain Fournier; Hubert Vaudry; Youssef Anouar; Laurent Yon
Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells.
Regulatory peptides 2006;137(1-2):79-88.
2006: Nicolas Aubert; Anthony Falluel-Morel; David Vaudry; Xavier Xifro; José Rodriguez-Alvarez; Cecile Fisch; Stéphane De Jouffrey; Jean-François Lebigot; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Journal of neurochemistry 2006;99(4):1237-50.
2006: Maite Montero-Hadjadje; Catherine Delarue; Alain Fournier; Hubert Vaudry; Laurent Yon
Involvement of the adenylyl cyclase/protein kinase A signaling pathway in the stimulatory effect of PACAP on frog adrenocortical cells.
Annals of the New York Academy of Sciences 2006;1070():431-5.
2006: Olfa Masmoudi-Kouki; Pierrick Gandolfo; Jérôme Leprince; David Vaudry; Georges Pelletier; Alain Fournier; Hubert Vaudry; Marie-Christine Tonon
PACAP stimulates biosynthesis and release of endozepines from rat astrocytes.
Annals of the New York Academy of Sciences 2006;1070():411-6.
2006: Alexis Lebon; Damien Seyer; Pascal Cosette; Laurent Coquet; THIERRY JOUENNE; Philippe Chan; Jérôme Leprince; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez; David Vaudry
Identification of proteins regulated by PACAP in PC12 cells by 2D gel electrophoresis coupled to mass spectrometry.
Annals of the New York Academy of Sciences 2006;1070():380-7.
2006: Johann Guillemot; Djida Ait-Ali; Valérie Turquier; Maite Montero-Hadjadje; Alain Fournier; Hubert Vaudry; Youssef Anouar; Laurent Yon
PACAP stimulates the release of the secretogranin II-derived peptide EM66 from chromaffin cells.
Annals of the New York Academy of Sciences 2006;1070():309-12.
2006: Anthony Falluel-Morel; David Vaudry; Nicolas Aubert; Ludovic Galas; Magalie Benard; Magali Basille; Marc Fontaine; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
PACAP and ceramides exert opposite effects on migration, neurite outgrowth, and cytoskeleton remodeling.
Annals of the New York Academy of Sciences 2006;1070():265-70.
2006: Hélène Castel; David Vaudry; Yan-Ai Mei; Thomas Lefebvre; Magali Basille; Laurence Desrues; Alain Fournier; Hubert Vaudry; Marie-Christine Tonon; Bruno J Gonzalez
The delayed rectifier channel current IK plays a key role in the control of programmed cell death by PACAP and ethanol in cerebellar granule neurons.
Annals of the New York Academy of Sciences 2006;1070():173-9.
2006: Aurélia Ravni; Steve Bourgault; Alexis Lebon; Philippe Chan; Ludovic Galas; Alain Fournier; Hubert Vaudry; Bruno Gonzalez; Lee E Eiden; David Vaudry
The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways.
Journal of neurochemistry 2006;98(2):321-9.
2006: Magali Basille; Dorthe Cartier; David Vaudry; Isabelle Lihrmann; Alain Fournier; Pierre Freger; Nicole Gallo-Payet; Hubert Vaudry; Bruno Gonzalez
Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
The Journal of comparative neurology 2006;496(4):468-78.
2006: Stéphane Boivin; Laure Guilhaudis; Isabelle Milazzo; Hassan Oulyadi; Daniel Davoust; Alain Fournier
Characterization of urotensin-II receptor structural domains involved in the recognition of U-II, URP, and urantide.
Biochemistry 2006;45(19):5993-6002.
2005: Yvan Dumont; Pierrette Gaudreau; Manuela Mazzuferi; Daniel Langlois; Jean-Guy Chabot; Alain Fournier; Michele Simonato; Rémi Quirion
BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
British journal of pharmacology 2005;146(8):1069-81.
2005: Yvan Dumont; Emmanuel Moyse; Alain Fournier; Rémi Quirion
Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain.
The Journal of pharmacology and experimental therapeutics 2005;315(1):99-108.
2005: Anthony Falluel-Morel; David Vaudry; Nicolas Aubert; Ludovic Galas; Magalie Bernard; Magali Basille; Marc Fontaine; Alain Fournier; Hubert Vaudry; Bruno J Gonzales
[Effects of PACAP and C2-ceramide on motility of cerebellar granule neurons: the fastest is not the farthest].
Médecine sciences : M/S 2005;21(8-9):696-8.
2005: John Redrobe; Yvan Dumont; Alain Fournier; Glen B Baker; Rémi Quirion
Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test.
Peptides 2005;26(8):1394-400.
2005: Romain Thuau; Laure Guilhaudis; Isabelle Ségalas-Milazzo; Nicolas Chartrel; Hassan Oulyadi; Stéphane Boivin; Alain Fournier; Jérôme Leprince; Daniel Davoust; Hubert Vaudry
Structural studies on 26RFa, a novel human RFamide-related peptide with orexigenic activity.
Peptides 2005;26(5):779-89.
2005: Anthony Falluel-Morel; David Vaudry; Nicolas Aubert; Ludovic Galas; Magalie Benard; Magali Basille; Marc Fontaine; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(7):2637-42.
2005: Catherine Delarue; Isabelle Remy Jouet; Marjorie Gras; Ludovic Galas; Alain Fournier; Hubert Vaudry
Activation of endothelinA receptors in frog adrenocortical cells stimulates both calcium mobilization from intracellular stores and calcium influx through L-type calcium channels.
Endocrinology 2005;146(1):119-29.
2004: David Vaudry; Cécile Cottet-Rousselle; Magali Basille; Anthony Falluel-Morel; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against beta-amyloid (25-35)-induced apoptosis.
Regulatory peptides 2004;123(1-3):43-9.
2004: Anthony Falluel-Morel; Nicolas Aubert; David Vaudry; Magali Basille; Marc Fontaine; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells.
Journal of neurochemistry 2004;91(5):1231-43.
2004: Yvan Dumont; Mira Thakur; Annette G Beck-Sickinger; Alain Fournier; Rémi Quirion
Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Neuropeptides 2004;38(4):163-74.
2004: Yan-Ai Mei; David Vaudry; Magali Basille; Hélène Castel; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
PACAP inhibits delayed rectifier potassium current via a cAMP/PKA transduction pathway: evidence for the involvement of I k in the anti-apoptotic action of PACAP.
The European journal of neuroscience 2004;19(6):1446-58.
2004: Catherine Delarue; J Michael Conlon; I Remy-Jouet; Alain Fournier; Hubert Vaudry
Endothelins as local activators of adrenocortical cells.
Journal of molecular endocrinology 2004;32(1):1-7.
2003: Alexandre Brkovic; Almut Hattenberger; Evi Kostenis; Thomas Klabunde; Stefanie Flohr; Michael Kurz; Steve Bourgault; Alain Fournier
Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay.
The Journal of pharmacology and experimental therapeutics 2003;306(3):1200-9.
2003: Yvan Dumont; Mira Thakur; Annette G Beck-Sickinger; Alain Fournier; Rémi Quirion
Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
British journal of pharmacology 2003;139(7):1360-8.
2003: Donata Rodi; Manuela Mazzuferi; Gianni Bregola; Yvan Dumont; Alain Fournier; Rémi Quirion; Michele Simonato
Changes in NPY-mediated modulation of hippocampal [3H]D-aspartate outflow in the kindling model of epilepsy.
Synapse (New York, N.Y.) 2003;49(2):116-24.
2003: Leng Hong Pheng; Yvan Dumont; Alain Fournier; Jean-Guy Chabot; Alain Beaudet; Rémi Quirion
Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells.
British journal of pharmacology 2003;139(4):695-704.
2003: Luca Grumolato; Abdel G Elkahloun; Hafida Ghzili; David Alexandre; Cedric Coulouarn; Laurent Yon; Jean-Philippe Salier; Lee E Eiden; Alain Fournier; Hubert Vaudry; Youssef Anouar
Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion.
Endocrinology 2003;144(6):2368-79.
2003: David Vaudry; Anthony Falluel-Morel; Magali Basille; Tommy F Pamantung; Marc Fontaine; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells.
Journal of neuroscience research 2003;72(3):303-16.
2003: Danielle Jacques; Sawsan Sader; Claudine Perreault; Alain Fournier; Georges Pelletier; Annette G Beck-Sickinger; Magda Descorbeth
Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium.
Canadian journal of physiology and pharmacology 2003;81(3):288-300.
2003: Marcel D Payet; Lyne Bilodeau; Lyne Breault; Alain Fournier; Laurent Yon; Hubert Vaudry; Nicole Gallo-Payet
PAC1 receptor activation by PACAP-38 mediates Ca2+ release from a cAMP-dependent pool in human fetal adrenal gland chromaffin cells.
The Journal of biological chemistry 2003;278(3):1663-70.
2003: Luca Grumolato; Estelle Louiset; David Alexandre; Djida Aït-Ali; Valérie Turquier; Alain Fournier; Aldo Fasolo; Hubert Vaudry; Youssef Anouar
PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells.
The European journal of neuroscience 2003;17(1):71-82.
2003: Olfa Masmoudi; Pierrick Gandolfo; Jérôme Leprince; David Vaudry; Alain Fournier; Christine Patte-Mensah; Hubert Vaudry; Marie-Christine Tonon
Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(1):17-27.
2002: Valérie Turquier; Laurent Yon; Luca Grumolato; David Alexandre; Alain Fournier; Hubert Vaudry; Youssef Anouar
Pituitary adenylate cyclase--activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells.
Annals of the New York Academy of Sciences 2002;971():471-3.
2002: Luca Grumolato; David Alexandre; Valérie Turquier; Djida Ait-Ali; Alain Fournier; Hubert Vaudry; Youssef Anouar
Pituitary adenylate cyclase-activating polypeptide regulates neuroendocrine markers and transcription factors in differentiating pheochromocytoma cells.
Annals of the New York Academy of Sciences 2002;971():467-70.
2002: Hervé Tostivint; Didier Vieau; Nicolas Chartrel; Isabelle Boutelet; Ludovic Galas; Alain Fournier; Isabelle Lihrmann; Hubert Vaudry
Expression and processing of the [Pro(2),Met(13)]somatostatin-14 precursor in the intermediate lobe of the frog pituitary.
Endocrinology 2002;143(9):3472-81.
2002: David Alexandre; Hubert Vaudry; Luca Grumolato; Valérie Turquier; Alain Fournier; Sylvie Jégou; Youssef Anouar
Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
Endocrinology 2002;143(7):2680-92.
2002: David Vaudry; Tommy F Pamantung; Magali Basille; C Rousselle; Alain Fournier; Hubert Vaudry; J C Beauvillain; Bruno J Gonzalez
PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis.
The European journal of neuroscience 2002;15(9):1451-60.
2002: Delphine Beaujean; Jean-Luc Do-Rego; Ludovic Galas; Ayikoe G Mensah-Nyagan; Robert Fredriksson; Dan Larhammar; Alain Fournier; Van Luu-The; Georges Pelletier; Hubert Vaudry
Neuropeptide Y inhibits the biosynthesis of sulfated neurosteroids in the hypothalamus through activation of Y(1) receptors.
Endocrinology 2002;143(5):1950-63.
2002: Ludovic Galas; Marie-Christine Tonon; Delphine Beaujean; Robert Fredriksson; Dan Larhammar; Isabelle Lihrmann; Sylvie Jegou; Alain Fournier; Nicolas Chartrel; Hubert Vaudry
Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.
Endocrinology 2002;143(5):1686-94.
2002: John Redrobe; Yvan Dumont; Alain Fournier; Rémi Quirion
The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(5):615-24.
2002: David Vaudry; Cécile Rousselle; Magali Basille; Anthony Falluel-Morel; Tommy F Pamantung; Marc Fontaine; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(9):6398-403.
2001: Y Wang; J Jensen; Peter W Abel; Alain Fournier; S Holmgren; J Michael Conlon
Effects of trout endothelin on the motility of gastrointestinal smooth muscle from the trout and rat.
General and comparative endocrinology 2001;123(2):156-62.
2001: Laurent Yon; David Alexandre; M Montéro; Nicolas Chartrel; L Jeandel; Mauro Vallarino; J Michael Conlon; Sakae Kikuyama; Alain Fournier; Francisco Gracia-Navarro; Eric W Roubos; B Chow; A Arimura; Youssef Anouar; Hubert Vaudry
Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians.
Microscopy research and technique 2001;54(3):137-57.
2001: Valérie Turquier; Laurent Yon; Luca Grumolato; David Alexandre; Alain Fournier; Hubert Vaudry; Youssef Anouar
Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1-like transcription factors.
Molecular pharmacology 2001;60(1):42-52.
2001: F Cartier; Jean-Luc Do-Rego; I Remy-Jouet; Alain Fournier; Hubert Vaudry; Catherine Delarue
Evidence for the involvement of nitric oxide in the control of steroid secretion by the frog adrenal gland.
The Journal of steroid biochemistry and molecular biology 2001;77(4-5):251-9.
2000: David Vaudry; Bruno J Gonzalez; Magali Basille; Tommy F Pamantung; Marc Fontaine; Alain Fournier; Hubert Vaudry
The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(24):13390-5.
2000: Magali Basille; David Vaudry; Y Coulouarn; Sylvie Jegou; Isabelle Lihrmann; Alain Fournier; Hubert Vaudry; Bruno Gonzalez
Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
The Journal of comparative neurology 2000;425(4):495-509.
2000: David Vaudry; Bruno J Gonzalez; Magali Basille; Laurent Yon; Alain Fournier; Hubert Vaudry
Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.
Pharmacological reviews 2000;52(2):269-324.
2000: Y Wang; I Remy-Jouet; Catherine Delarue; M Letourneau; Alain Fournier; Hubert Vaudry; J Michael Conlon
Structural characterization and effects on corticosteroid secretion of endothelin-1 and endothelin-3 from the frog Rana ridibunda.
Journal of molecular endocrinology 2000;24(2):285-93.
2000: Yvan Dumont; Alain Cadieux; Henry Doods; Alain Fournier; Rémi Quirion
Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
Canadian journal of physiology and pharmacology 2000;78(2):116-25.
2000: Lyne Breault; Laurent Yon; M Montéro; Lucie Chouinard; Vincent Contesse; Catherine Delarue; Alain Fournier; Jean-Guy LeHoux; Hubert Vaudry; Nicole Gallo-Payet
Occurrence and effect of PACAP in the human fetal adrenal gland.
Annals of the New York Academy of Sciences 2000;921():429-33.
2000: Magali Basille; David Vaudry; Y Coulouarn; Sylvie Jégou; Isabelle Lihrmann; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
Distribution of PACAP receptor mRNAs and PACAP binding sites in the rat brain during development.
Annals of the New York Academy of Sciences 2000;921():304-7.
2000: David Alexandre; Youssef Anouar; Sylvie Jégou; Alain Fournier; Hubert Vaudry
Molecular cloning, mRNA distribution and pharmacological characterization of a VIP/PACAP receptor in the frog Rana ridibunda.
Annals of the New York Academy of Sciences 2000;921():300-3.
2000: David Vaudry; Bruno J Gonzalez; Magali Basille; Tommy F Pamantung; Alain Fournier; Hubert Vaudry
PACAP acts as a neurotrophic factor during histogenesis of the rat cerebellar cortex.
Annals of the New York Academy of Sciences 2000;921():293-9.
2000: Gianni Bregola; Yvan Dumont; Alain Fournier; Silvia Zucchini; Rémi Quirion; Michele Simonato
Decreased levels of neuropeptide Y(5) receptor binding sites in two experimental models of epilepsy.
Neuroscience 2000;98(4):697-703.
1999: L Jeandel; Laurent Yon; Nicolas Chartrel; Bruno Gonzalez; Alain Fournier; J Michael Conlon; Hubert Vaudry
Characterization and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites in the brain of the frog Rana ridibunda.
The Journal of comparative neurology 1999;412(2):218-28.
1999: David Vaudry; Bruno J Gonzalez; Magali Basille; Alain Fournier; Hubert Vaudry
Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(16):9415-20.
1999: David Alexandre; Youssef Anouar; Sylvie Jegou; Alain Fournier; Hubert Vaudry
A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Endocrinology 1999;140(3):1285-93.
1999: F Cartier; Catherine Delarue; I Remy-Jouet; MK Kodjo; Alain Fournier; Hubert Vaudry
The stimulatory effect of endothelin-1 on frog adrenocortical cells is mediated through both the phospholipase C and the adenylyl cyclase transduction pathways.
Molecular and cellular endocrinology 1999;147(1-2):27-36.
1999: Alain Cadieux; N P Monast; Francois Pomerleau; Alain Fournier; C Lanoue
Bronchoprotector properties of calcitonin gene-related peptide in guinea pig and human airways. Effect of pulmonary inflammation.
American journal of respiratory and critical care medicine 1999;159(1):235-43.
1998: M Montero; Laurent Yon; K Rousseau; A Arimura; Alain Fournier; S Dufour; Hubert Vaudry
Localization of pituitary adenylate cyclase-activating polypeptide in the central nervous system of the European eel Anguilla anguilla: stimulatory effect of PACAP on GH secretion.
Annals of the New York Academy of Sciences 1998;865():475-7.
1998: Laurent Yon; Lyne Breault; Vincent Contesse; G Bellancourt; Catherine Delarue; Alain Fournier; Jean-Guy LeHoux; Nicole Gallo-Payet; Hubert Vaudry
Pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland.
Annals of the New York Academy of Sciences 1998;865():416-9.
1998: David Vaudry; Magali Basille; Youssef Anouar; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez
The neurotrophic activity of PACAP on rat cerebellar granule cells is associated with activation of the protein kinase A pathway and c-fos gene expression.
Annals of the New York Academy of Sciences 1998;865():92-9.
1998: Bruno J Gonzalez; Magali Basille; David Vaudry; Alain Fournier; Hubert Vaudry
[Pituitary adenylate cyclase-activating polypeptide].
Annales d'endocrinologie 1998;59(5):364-405.
1998: M Montero; Laurent Yon; K Rousseau; A Arimura; Alain Fournier; S Dufour; Hubert Vaudry
Distribution, characterization, and growth hormone-releasing activity of pituitary adenylate cyclase-activating polypeptide in the European eel, Anguilla anguilla.
Endocrinology 1998;139(10):4300-10.
1998: Lyne Breault; Laurent Yon; M Montéro; Vincent Contesse; Catherine Delarue; Alain Fournier; Jean-Guy LeHoux; Hubert Vaudry; Nicole Gallo-Payet
Presence of PACAP and PACAP receptors in the human adrenal gland: possible role in fetal development.
Endocrine research 1998;24(3-4):961-2.
1998: Yvan Dumont; Alain Fournier; Rémi Quirion
Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(15):5565-74.
1998: Alain Fournier; M Podtetenev; J Lemire; P Thompson; R Duchesne; Claudine Perreault; N Chehade; Pierre Blondeau
Intraocular pressure change measured by Goldmann tonometry after laser in situ keratomileusis.
Journal of cataract and refractive surgery 1998;24(7):905-10.
1998: I Remy-Jouet; F Cartier; O Lesouhaitier; Jean-Marc Kuhn; Alain Fournier; Hubert Vaudry; Catherine Delarue
Mechanism of action of endothelins on adrenocortical cells.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1998;30(6-7):341-5.
1998: David Vaudry; Bruno J Gonzalez; Magali Basille; Youssef Anouar; Alain Fournier; Hubert Vaudry
Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway.
Neuroscience 1998;84(3):801-12.
1998: F Cartier; I Remy-Jouet; Alain Fournier; Hubert Vaudry; Catherine Delarue
Mechanism of action of endothelin-1 in the frog adrenal gland.
Annals of the New York Academy of Sciences 1998;839():526-8.
1998: Hervé Tostivint; Isabelle Lihrmann; Christine Bucharles; Didier Vieau; Y Coulouarn; Isabelle Boutelet; Alain Fournier; J Michael Conlon; Hubert Vaudry
A second somatostatin gene is expressed in the brain of the frog Rana ridibunda.
Annals of the New York Academy of Sciences 1998;839():496-7.
1998: Laurent Yon; M Montero; G Bellancourt; Alain Fournier; Nicolas Chartrel; Hubert Vaudry
Involvement of pituitary adenylate cyclase-activating polypeptide in the regulation of frog adrenal steroidogenesis.
Annals of the New York Academy of Sciences 1998;839():384-5.
1998: Laurent Yon; Lyne Breault; Vincent Contesse; G Bellancourt; Catherine Delarue; Alain Fournier; Jean-Guy LeHoux; Hubert Vaudry; Nicole Gallo-Payet
Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation.
The Journal of clinical endocrinology and metabolism 1998;83(4):1299-305.
1998: L Jeandel; A Okuno; T Kobayashi; Sakae Kikuyama; Hervé Tostivint; Isabelle Lihrmann; Nicolas Chartrel; J Michael Conlon; Alain Fournier; Marie-Christine Tonon; Hubert Vaudry
Effects of the two somatostatin variants somatostatin-14 and [Pro2, Met13]somatostatin-14 on receptor binding, adenylyl cyclase activity and growth hormone release from the frog pituitary.
Journal of neuroendocrinology 1998;10(3):187-92.
1997: F Cartier; I Remy-Jouet; Alain Fournier; Hubert Vaudry; Catherine Delarue
Effect of endothelin-1 on corticosteroid secretion by the frog adrenal gland is mediated by an endothelinA receptor.
Endocrinology 1997;138(10):4358-63.
1997: Catherine Delarue; M Esneu; Alain Fournier; Hubert Vaudry
Role of the cytoskeleton in the secretory response of the frog adrenal gland to calcitonin gene-related peptide.
The Journal of steroid biochemistry and molecular biology 1997;63(1-3):21-7.
1997: Francois Pomerleau; Alain Fournier; Alain Cadieux
Mouse aorta: a preparation highly sensitive to the vasodilatory action of CGRP.
Journal of cardiovascular pharmacology 1997;30(3):343-51.
1997: Leng Hong Pheng; Rémi Quirion; S Iyengar; Alain Fournier; Domenico Regoli
The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor.
European journal of pharmacology 1997;333(2-3):R3-5.
1997: D Jacques; Yvan Dumont; Alain Fournier; Rémi Quirion
Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus.
Neuroscience 1997;79(1):129-48.
1997: K Lewis; Pedro D'Orléans-Juste; Majda Taoudi Benchekroun; Alain Fournier; Alain Cadieux
Effect of neuropeptide Y on bradykinin-induced release of prostacyclin and thromboxane from guinea pig perfused lung.
Canadian journal of physiology and pharmacology 1997;75(6):677-82.
1997: Yvan Dumont; Alain Fournier; S St-Pierre; Rémi Quirion
A potent and selective CGRP2 agonist, [Cys(Et)2,7]hCGRP alpha: comparison in prototypical CGRP1 and CGRP2 in vitro bioassays.
Canadian journal of physiology and pharmacology 1997;75(6):671-6.
1997: Leng Hong Pheng; Alain Fournier; Yvan Dumont; Rémi Quirion; Domenico Regoli
The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y.
European journal of pharmacology 1997;327(2-3):163-7.
1997: Bruno J Gonzalez; Magali Basille; David Vaudry; Alain Fournier; Hubert Vaudry
Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts.
Neuroscience 1997;78(2):419-30.
1996: Laurent Yon; Nicolas Chartrel; M Montero; G Bellancourt; Marc G J Feuilloley; Georges Pelletier; Eric W Roubos; A Arimura; J Michael Conlon; Alain Fournier; Hubert Vaudry
Pituitary adenylate cyclase-activating polypeptide regulates both adrenocortical and chromaffin cell activity in the frog adrenal gland.
Annals of the New York Academy of Sciences 1996;805():697-701.
1996: B J Gonzalez; Magali Basille; Yan-Ai Mei; David Vaudry; Alain Fournier; L Cazin; Hubert Vaudry
Ontogeny of PACAP and PACAP receptors in the rat brain: role of PACAP in the cerebellum during development.
Annals of the New York Academy of Sciences 1996;805():302-13; discussion 313-4.
1996: S Gasman; Hubert Vaudry; F Cartier; G Tramu; Alain Fournier; J Michael Conlon; Catherine Delarue
Localization, identification, and action of galanin in the frog adrenal gland.
Endocrinology 1996;137(12):5311-8.
1996: Hervé Tostivint; Isabelle Lihrmann; Christine Bucharles; Didier Vieau; Y Coulouarn; Alain Fournier; J Michael Conlon; Hubert Vaudry
Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(22):12605-10.
1996: M Esneu; Catherine Delarue; Alain Fournier; Hubert Vaudry
Characterization of the receptor mediating the effect of calcitonin gene-related peptide in the frog adrenal gland.
European journal of pharmacology 1996;308(2):187-93.
1996: Yvan Boulanger; Abdesslem Khiat; A Larocque; Alain Fournier; SA St-Pierre
Structural comparison of alanine-substituted analogues of the calcitonin gene-related peptide 8-37. Importance of the C-terminal segment for antagonistic activity.
International journal of peptide and protein research 1996;47(6):477-83.
1996: János G Filep; Y Skrobik; Alain Fournier; E Földes-Filep
Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the rat.
British journal of pharmacology 1996;118(4):893-900.
1996: M A Forget; N Lebel; P Sirois; Yvan Boulanger; Alain Fournier
Biological and molecular analyses of structurally reduced analogues of endothelin-1.
Molecular pharmacology 1996;49(6):1071-9.
1996: V Bodart; William E Rainey; Alain Fournier; Huy Ong; André De Léan
The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis.
Molecular and cellular endocrinology 1996;118(1-2):137-44.
1996: Yvan Dumont; Alain Fournier; S St-Pierre; Rémi Quirion
Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands.
Synapse (New York, N.Y.) 1996;22(2):139-58.
1996: N Lebel; Pedro D'Orléans-Juste; Alain Fournier; Pierre Sirois
Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma.
British journal of pharmacology 1996;117(1):184-8.
1995: SG Bernier; Guy Servant; M Boudreau; Alain Fournier; Gaétan Guillemette
Characterization of a binding site for angiotensin IV on bovine aortic endothelial cells.
European journal of pharmacology 1995;291(2):191-200.
1995: G H Allcock; B Battistini; Alain Fournier; T D Warner; JR Vane
Characterization of endothelin receptors mediating mechanical responses to the endothelins in the isolated stomach strip of the rat.
The Journal of pharmacology and experimental therapeutics 1995;275(1):120-6.
1995: János G Filep; Alain Fournier; E Földes-Filep
Effects of the ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischaemia and oedema in the rat.
British journal of pharmacology 1995;116(2):1745-50.
1995: Magali Basille; B J Gonzalez; Laurence Desrues; M Demas; Alain Fournier; Hubert Vaudry
Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylyl cyclase and phospholipase C activity in rat cerebellar neuroblasts.
Journal of neurochemistry 1995;65(3):1318-24.
1995: C Blasquez; Sylvie Jégou; O Friard; Marie-Christine Tonon; Alain Fournier; Hubert Vaudry
Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal proopiomelanocortin-derived peptides in the rat.
Neuroscience 1995;68(1):221-7.
1995: Yvan Boulanger; Abdesslem Khiat; Y Chen; L Senécal; Y Tu; SA St-Pierre; Alain Fournier
Structure of human calcitonin gene-related peptide (hCGRP) and of its antagonist hCGRP 8-37 as determined by NMR and molecular modeling.
Peptide research 1995;8(4):206-13.
1995: Nicolas Chartrel; Y Wang; Alain Fournier; Hubert Vaudry; J Michael Conlon
Frog vasoactive intestinal polypeptide and galanin: primary structures and effects on pituitary adenylate cyclase.
Endocrinology 1995;136(7):3079-86.
1995: O Lesouhaitier; M Esneu; MK Kodjo; C Hamel; Vincent Contesse; Laurent Yon; I Remy-Jouet; Aldo Fasolo; Alain Fournier; Frans Vandesand
Neuroendocrine communication in the frog adrenal gland.
Zoological science 1995;12(3):255-64.
1995: János G Filep; Alain Fournier; E Földes-Filep
Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors.
British journal of pharmacology 1995;115(2):227-36.
1995: B Battistini; M Woods; L J O'Donnell; T D Warner; Roger Corder; Alain Fournier; M J Farthing; JR Vane
Contractile activity of endothelin precursors in the isolated gallbladder of the guinea-pig: presence of an endothelin-converting enzyme.
British journal of pharmacology 1995;114(7):1383-90.
1995: S M Bouali; Alain Fournier; S St-Pierre; F B Jolicoeur
Influence of ambient temperature on the effects of NPY on body temperature and food intake.
Pharmacology, biochemistry, and behavior 1995;50(3):473-5.
1995: Yvan Dumont; Alain Fournier; S St-Pierre; Rémi Quirion
Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.
The Journal of pharmacology and experimental therapeutics 1995;272(2):673-80.
1995: M Mimeault; André De Léan; M Lafleur; D Bonenfant; Alain Fournier
Evaluation of conformational and binding characteristics of various natriuretic peptides and related analogs.
Biochemistry 1995;34(3):955-64.
1995: N Lebel; Pedro D'Orléans-Juste; Alain Fournier; Pierre Sirois
Characterization of the endothelin-converting enzyme in guinea pig upper bronchus.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S81-3.
1995: M A Forget; N Lebel; P Sirois; Yvan Boulanger; B Battistini; Alain Fournier
Structure-activity studies of the C-terminal segment of structurally reduced analogues of ET-1.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S107-10.
1995: S M Bouali; Alain Fournier; S St-Pierre; F B Jolicoeur
Effects of NPY and NPY2-36 on body temperature and food intake following administration into hypothalamic nuclei.
Brain research bulletin 1995;36(2):131-5.
1995: F B Jolicoeur; S M Bouali; Alain Fournier; S St-Pierre
Mapping of hypothalamic sites involved in the effects of NPY on body temperature and food intake.
Brain research bulletin 1995;36(2):125-9.
1995: Jean-Luc Bigras; Alain Fournier; Brian W McCrindle; D Cartwright; André Davignon; Jean-Marie Leclerc
Functional cardiac disturbances related to chemotherapy independent of anthracycline use in children with neoplastic disease.
The American journal of cardiology 1995;75(1):101-3.
1995: Yvan Boulanger; Y Chen; F Commodari; L Senécal; A M Laberge; Alain Fournier; SA St-Pierre
Structural characterizations of neuropeptide tyrosine (NPY) and its agonist analog [Ahx5-17]NPY by NMR and molecular modeling.
International journal of peptide and protein research 1995;45(1):86-95.
1995: F B Jolicoéur; S M Bouali; J N Michaud; D Ménard; Alain Fournier; S St-Pierre
Structure-activity analysis of the motor effects of neuropeptide Y.
Brain research bulletin 1995;37(1):1-4.
1994: S M Bouali; Alain Fournier; F B Jolicoeur
Differential effects of pertussis toxin on body temperature changes induced by neuropeptide Y and NPY2-36.
Regulatory peptides 1994;54(2-3):367-72.
1994: SG Bernier; Alain Fournier; Gaétan Guillemette
A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes.
European journal of pharmacology 1994;271(1):55-63.
1994: Laurent Yon; Nicolas Chartrel; Marc G J Feuilloley; S De Marchis; Alain Fournier; E De Rijk; Georges Pelletier; Eric W Roubos; Hubert Vaudry
Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland.
Endocrinology 1994;135(6):2749-58.
1994: János G Filep; M Clozel; Alain Fournier; E Földes-Filep
Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat.
British journal of pharmacology 1994;113(3):845-52.
1994: A Drumheller; S M Bouali; Alain Fournier; S St-Pierre; F B Jolicoeur
Neurochemical effects of neuropeptide Y (NPY) and NPY2-36.
Neuropeptides 1994;27(5):291-6.
1994: Magali Basille; B J Gonzalez; Alain Fournier; Hubert Vaudry
Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the rat cerebellum: a quantitative autoradiographic study.
Brain research. Developmental brain research 1994;82(1-2):81-9.
1994: D van Rossum; D P Ménard; Alain Fournier; S St-Pierre; Rémi Quirion
Autoradiographic distribution and receptor binding profile of [125I]Bolton Hunter-rat amylin binding sites in the rat brain.
The Journal of pharmacology and experimental therapeutics 1994;270(2):779-87.
1994: B Battistini; L J O'Donnell; T D Warner; Alain Fournier; M J Farthing; JR Vane
Characterization of endothelin (ET) receptors in the isolated gall bladder of the guinea-pig: evidence for an additional ET receptor subtype.
British journal of pharmacology 1994;112(4):1244-50.
1994: M Esneu; Catherine Delarue; I Remy-Jouet; E Manzardo; Aldo Fasolo; Alain Fournier; S Saint-Pierre; J Michael Conlon; Hubert Vaudry
Localization, identification, and action of calcitonin gene-related peptide in the frog adrenal gland.
Endocrinology 1994;135(1):423-30.
1994: János G Filep; Alain Fournier; E Földes-Filep
Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
British journal of pharmacology 1994;112(3):963-71.
1994: D Van Rossum; D P Ménard; Alain Fournier; S St-Pierre; Rémi Quirion
Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.
The Journal of pharmacology and experimental therapeutics 1994;269(2):846-53.
1994: B Battistini; T D Warner; Alain Fournier; JR Vane
Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065.
British journal of pharmacology 1994;111(4):1009-16.
1994: B Battistini; T D Warner; Alain Fournier; JR Vane
Comparison of PD 145065 and Ro 46-2005 as antagonists of contractions of guinea-pig airways induced by endothelin-1 or IRL 1620.
European journal of pharmacology 1994;252(3):341-5.
1994: Alain Fournier; D Gagnon; R Quirion; Alain Cadieux; Yvan Dumont; Leng Hong Pheng; S St-Pierre
Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
Molecular pharmacology 1994;45(1):93-101.
1994: S M Bouali; Alain Fournier; S St-Pierre; F B Jolicoeur
In vivo central actions of NPY(1-30), an N-terminal fragment of neuropeptide Y.
Peptides 1994;15(5):799-802.
1993: Laurent Yon; Marc G J Feuilloley; Nicolas Chartrel; A Arimura; Alain Fournier; Hubert Vaudry
Localization, characterization and activity of pituitary adenylate cyclase-activating polypeptide in the frog adrenal gland.
The Journal of endocrinology 1993;139(2):183-94.
1993: János G Filep; E Földes-Filep; A Rousseau; Pierre Sirois; Alain Fournier
Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat.
British journal of pharmacology 1993;110(3):1213-21.
1993: Magali Basille; B J Gonzalez; Philippe Leroux; L Jeandel; Alain Fournier; Hubert Vaudry
Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells.
Neuroscience 1993;57(2):329-38.
1993: János G Filep; Bruno Battistini; Alain Fournier; Pierre Sirois
Relaxation by dexamethasone of isolated guinea-pig airways precontracted with endothelin-1.
European journal of pharmacology 1993;240(2-3):315-8.
1993: M Taoudi Benchekroun; S St-Pierre; Alain Fournier; Alain Cadieux
Antagonism of the inhibitory action of neuropeptide Y (NPY) in guinea-pig trachea by the C-terminal fragment NPY (2-36).
British journal of pharmacology 1993;109(4):902-4.
1993: Alain Cadieux; Leng Hong Pheng; S St-Pierre; Alain Fournier; M T Benchekroun
The rabbit saphenous vein: a tissue preparation specifically enriched in NPY-Y1 receptor subtype.
Regulatory peptides 1993;46(3):557-64.
1993: Yvan Dumont; H Satoh; Alain Cadieux; M Taoudi-Benchekroun; Leng Hong Pheng; S St-Pierre; Alain Fournier; Rémi Quirion
Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types.
European journal of pharmacology 1993;238(1):37-45.
1993: János G Filep; M G Sirois; E Földes-Filep; A Rousseau; Gérard E Plante; Alain Fournier; M Yano; Pierre Sirois
Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors.
British journal of pharmacology 1993;109(3):880-6.
1993: Laurent Yon; L Jeandel; Nicolas Chartrel; Marc G J Feuilloley; J Michael Conlon; A Arimura; Alain Fournier; Hubert Vaudry
Neuroanatomical and physiological evidence for the involvement of pituitary adenylate cyclase-activating polypeptide in the regulation of the distal lobe of the frog pituitary.
Journal of neuroendocrinology 1993;5(3):289-96.
1993: Alain Fournier; A Couvineau; M Laburthe
Synthesis of a hydrophilic affinity matrix for the purification of the vasoactive intestinal peptide receptor.
Analytical biochemistry 1993;211(2):305-10.
1993: C Blasquez; Sylvie Jegou; Alain Fournier; D Tranchand Bunel; Hubert Vaudry
Regulation of neuronal alpha-melanocyte-stimulating hormone by neuropeptide Y. In vitro and in vivo studies.
Annals of the New York Academy of Sciences 1993;680():466-9.
1993: M Mimeault; S St-Pierre; Alain Fournier
Conformational characterization by circular-dichroism spectroscopy of various fragments and analogs of calcitonin-gene-related peptide.
European journal of biochemistry / FEBS 1993;213(3):927-34.
1993: M Mimeault; Alain Fournier; J Féthiere; André De Léan
Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype.
Molecular pharmacology 1993;43(5):775-82.
1993: M Germain; Bruno Battistini; János G Filep; P Sirois; Alain Fournier
Endothelin derivatives showing potent effects in the guinea pig trachea.
Peptides 1993;14(3):613-9.
1993: S Centazzo; M Montigny; André Davignon; C Chartrand; Alain Fournier; T Marchand
Use of acetylsalicylic acid to improve patency of subclavian to pulmonary artery Gore-Tex shunts.
The Canadian journal of cardiology 1993;9(3):243-6.
1993: M Poitras; SG Bernier; Guylain Boulay; Alain Fournier; Gaétan Guillemette
Interaction of benzene 1,2,4-trisphosphate with inositol 1,4,5-trisphosphate receptor and metabolizing enzymes.
European journal of pharmacology 1993;244(3):203-10.
1993: Yvan Dumont; Alain Fournier; S St-Pierre; Rémi Quirion
Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1993;13(1):73-86.
1993: Bruno Battistini; M Germain; Alain Fournier; Pierre Sirois
Structure-activity relationships of ET-1 and selected analogues in the isolated guinea pig trachea: evidence for the existence of different ETB receptor subtypes.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S219-24.
1992: F P Monnet; Guy Debonnel; Alain Fournier; Claude de Montigny
Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1219-25.
1992: F P Monnet; Alain Fournier; Guy Debonnel; Claude de Montigny
Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1212-8.
1992: A Claing; S Télémaque; Alain Cadieux; Alain Fournier; D Regoli; Pedro D'Orléans-Juste
Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1226-32.
1992: C Blasquez; Sylvie Jégou; D Tranchand Bunel; Alain Fournier; Hubert Vaudry
Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein.
Brain research 1992;596(1-2):163-8.
1992: Laurent Yon; Marc G J Feuilloley; Nicolas Chartrel; A Arimura; J Michael Conlon; Alain Fournier; Hubert Vaudry
Immunohistochemical distribution and biological activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nervous system of the frog Rana ridibunda.
The Journal of comparative neurology 1992;324(4):485-9.
1992: János G Filep; A Rousseau; Alain Fournier; Pierre Sirois
Structure-activity relationship of analogues of endothelin-1: dissociation of hypotensive and pressor actions.
European journal of pharmacology 1992;220(2-3):263-6.
1992: János G Filep; E Földes-Filep; A Rousseau; Alain Fournier; Pierre Sirois; M Yano
Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor.
European journal of pharmacology 1992;219(2):343-4.
1992: A Drumheller; D Menard; Alain Fournier; F B Jolicoeur
Neurochemical effects of CGRP.
Annals of the New York Academy of Sciences 1992;657():546-8.
1992: F B Jolicoeur; D Menard; Alain Fournier; S St-Pierre
Structure-activity analysis of CGRP's neurobehavioral effects.
Annals of the New York Academy of Sciences 1992;657():155-63.
1992: Rémi Quirion; D Van Rossum; Yvan Dumont; S St-Pierre; Alain Fournier
Characterization of CGRP1 and CGRP2 receptor subtypes.
Annals of the New York Academy of Sciences 1992;657():88-105.
1992: C Lanoue; Alain Fournier; S St-Pierre; Alain Cadieux
Characterization of CGRP receptor sites in rat airways.
Annals of the New York Academy of Sciences 1992;657():441-3.
1992: D Van Rossum; Yvan Dumont; Alain Fournier; S St-Pierre; Rémi Quirion
Effect of dithiothreitol and Gpp(NH)p on [125I] alpha-hCGRP binding sites in brain and peripheral tissues.
Annals of the New York Academy of Sciences 1992;657():429-31.
1992: M Mimeault; S St-Pierre; R Quirion; Yvan Dumont; Alain Fournier
Synthesis and structure-activity analysis of fragments and analogs of CGRP8-37.
Annals of the New York Academy of Sciences 1992;657():426-8.
1992: M T-Benchekroun; Alain Fournier; S St-Pierre; Alain Cadieux
Inhibitory action of neuropeptide Y on agonist-induced responses in isolated guinea pig trachea.
European journal of pharmacology 1992;216(3):421-8.
1992: M Mimeault; R Quirion; Yvan Dumont; S St-Pierre; Alain Fournier
Structure-activity study of hCGRP8-37, a calcitonin gene-related peptide receptor antagonist.
Journal of medicinal chemistry 1992;35(12):2163-8.
1992: M G Sirois; János G Filep; A Rousseau; Alain Fournier; Gérard E Plante; Pierre Sirois
Endothelin-1 enhances vascular permeability in conscious rats: role of thromboxane A2.
European journal of pharmacology 1992;214(2-3):119-25.
1992: Claude de Montigny; F P Monnet; Alain Fournier; Guy Debonnel
Sigma ligands and neuropeptide Y selectively potentiate the NMDA response in the rat CA3 dorsal hippocampus: in vivo electrophysiological studies.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():145A-146A.
1992: Yvan Dumont; J C Martel; Alain Fournier; S St-Pierre; Rémi Quirion
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues.
Progress in neurobiology 1992;38(2):125-67.
1991: János G Filep; M G Sirois; A Rousseau; Alain Fournier; Pierre Sirois
Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
British journal of pharmacology 1991;104(4):797-804.
1991: Sylvain Dore; G R Brisson; Alain Fournier; Denis Massicotte; François Péronnet; R Gareau
HGH20k species and variability of GH responses to long-duration exercise in male cyclists fed different food supplements.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1991;23(9):431-4.
1991: M Mimeault; Alain Fournier; Yvan Dumont; S St-Pierre; R Quirion
Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery.
The Journal of pharmacology and experimental therapeutics 1991;258(3):1084-90.
1991: J M Danger; B Breton; Mauro Vallarino; Alain Fournier; Georges Pelletier; Hubert Vaudry
Neuropeptide-Y in the trout brain and pituitary: localization, characterization, and action on gonadotropin release.
Endocrinology 1991;128(5):2360-8.
1991: Nicolas Chartrel; J Michael Conlon; J M Danger; Alain Fournier; Marie-Christine Tonon; Hubert Vaudry
Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(9):3862-6.
1991: Bruno Battistini; János G Filep; E J Cragoe; Alain Fournier; Pierre Sirois
A role for Na+/H+ exchange in contraction of guinea pig airways by endothelin-1 in vitro.
Biochemical and biophysical research communications 1991;175(2):583-8.
1991: F B Jolicoeur; J N Michaud; D Menard; Alain Fournier
In vivo structure activity study supports the existence of heterogeneous neuropeptide Y receptors.
Brain research bulletin 1991;26(2):309-11.
1991: F B Jolicoeur; J N Michaud; R Rivest; D Menard; D Gaudin; Alain Fournier; S St-Pierre
Neurobehavioral profile of neuropeptide Y.
Brain research bulletin 1991;26(2):265-8.
1991: T Dennis; Alain Fournier; S Guard; S St Pierre; Rémi Quirion
Calcitonin gene-related peptide (hCGRP alpha) binding sites in the nucleus accumbens. Atypical structural requirements and marked phylogenic differences.
Brain research 1991;539(1):59-66.
1991: Sylvain Dore; G R Brisson; Alain Fournier; R Montpetit; Hélène Perrault; D Boisvert
Contribution of hGH20K variant to blood hGH response in sauna and exercise.
European journal of applied physiology and occupational physiology 1991;62(2):130-4.
1990: Yvan Dumont; Alain Fournier; S St-Pierre; T W Schwartz; Rémi Quirion
Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain.
European journal of pharmacology 1990;191(3):501-3.
1990: J C Martel; Alain Fournier; S St-Pierre; Yvan Dumont; M Forest; Rémi Quirion
Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
Molecular pharmacology 1990;38(4):494-502.
1990: M Montigny; P Stanley; C Chartrand; E Selman; Alain Fournier; André Davignon
Postoperative evaluation after end-to-end subclavian-left coronary artery anastomosis in anomalous left coronary artery.
The Journal of thoracic and cardiovascular surgery 1990;100(2):270-3.
1990: T Dennis; Alain Fournier; Alain Cadieux; Francois Pomerleau; F B Jolicoeur; S St Pierre; Rémi Quirion
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery.
The Journal of pharmacology and experimental therapeutics 1990;254(1):123-8.
1990: Alain Cadieux; Francois Pomerleau; S St-Pierre; Alain Fournier
Inhibitory action of calcitonin gene-related peptide (CGRP) in the mouse colon.
The Journal of pharmacy and pharmacology 1990;42(7):520-1.
1990: M Forest; J C Martel; S St-Pierre; Rémi Quirion; Alain Fournier
Structural study of the N-terminal segment of neuropeptide tyrosine.
Journal of medicinal chemistry 1990;33(6):1615-9.
1990: Rémi Quirion; J C Martel; Yvan Dumont; Alain Cadieux; F Jolicoeur; S St-Pierre; Alain Fournier
Neuropeptide Y receptors: autoradiographic distribution in the brain and structure-activity relationships.
Annals of the New York Academy of Sciences 1990;611():58-72.
1989: Alain Cadieux; M T Benchekroun; S St-Pierre; Alain Fournier
Bronchoconstrictor action of neuropeptide Y (NPY) in isolated guinea pig airways.
Neuropeptides 1989;13(4):215-9.
1989: G Vaksmann; Alain Fournier; C Chartrand; P Stanley; André Davignon
[Arrhythmia disorders after repair of ventricular septal defects. Comparison of atrial and ventricular approaches].
Archives des maladies du coeur et des vaisseaux 1989;82(5):731-5.
1989: M Montigny; André Davignon; J C Fouron; P Biron; Alain Fournier; R Elie
Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt.
The American journal of cardiology 1989;63(9):631-3.
1988: M Jimenez; Alain Fournier; E Héry; M Montigny; C Kratz; C Chartrand; P Stanley; André Davignon
[Cardiac pacemakers in children. 15 years' experience].
Archives des maladies du coeur et des vaisseaux 1988;81(5):665-70.
1988: Alain Fournier; J K Saunders; Yvan Boulanger; S A St-Pierre
Conformational analysis of vasoactive intestinal peptide and related fragments.
Annals of the New York Academy of Sciences 1988;527():51-67.